» Articles » PMID: 23641360

Stochastic Hypothesis of Transition from Inborn Neutropenia to AML: Interactions of Cell Population Dynamics and Population Genetics

Overview
Journal Front Oncol
Specialty Oncology
Date 2013 May 4
PMID 23641360
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We present a stochastic model of driver mutations in the transition from severe congenital neutropenia to myelodysplastic syndrome to acute myeloid leukemia (AML). The model has the form of a multitype branching process. We derive equations for the distributions of the times to consecutive driver mutations and set up simulations involving a range of hypotheses regarding acceleration of the mutation rates in successive mutant clones. Our model reproduces the clinical distribution of times at diagnosis of secondary AML. Surprisingly, within the framework of our assumptions, stochasticity of the mutation process is incapable of explaining the spread of times at diagnosis of AML in this case; it is necessary to additionally assume a wide spread of proliferative parameters among disease cases. This finding is unexpected but generally consistent with the wide heterogeneity of characteristics of human cancers.

Citing Articles

Predicting Time to Relapse in Acute Myeloid Leukemia through Stochastic Modeling of Minimal Residual Disease Based on Clonality Data.

Dinh K, Jaksik R, Corey S, Kimmel M Comput Syst Oncol. 2021; 1(3).

PMID: 34541576 PMC: 8447492. DOI: 10.1002/cso2.1026.


Application of the Moran Model in Estimating Selection Coefficient of Mutated CSF3R Clones in the Evolution of Severe Congenital Neutropenia to Myeloid Neoplasia.

Dinh K, Corey S, Kimmel M Front Physiol. 2020; 11:806.

PMID: 33041834 PMC: 7527629. DOI: 10.3389/fphys.2020.00806.


Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.

Wojdyla T, Mehta H, Glaubach T, Bertolusso R, Iwanaszko M, Braun R PLoS Comput Biol. 2019; 15(1):e1006664.

PMID: 30615612 PMC: 6336352. DOI: 10.1371/journal.pcbi.1006664.


Phenotypic equilibrium as probabilistic convergence in multi-phenotype cell population dynamics.

Jiang D, Wang Y, Zhou D PLoS One. 2017; 12(2):e0170916.

PMID: 28182672 PMC: 5300154. DOI: 10.1371/journal.pone.0170916.


Tumor evolution: Linear, branching, neutral or punctuated?.

Davis A, Gao R, Navin N Biochim Biophys Acta Rev Cancer. 2017; 1867(2):151-161.

PMID: 28110020 PMC: 5558210. DOI: 10.1016/j.bbcan.2017.01.003.


References
1.
Beekman R, Valkhof M, Sanders M, van Strien P, Haanstra J, Broeders L . Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012; 119(22):5071-7. DOI: 10.1182/blood-2012-01-406116. View

2.
Rosenberg P, Zeidler C, Bolyard A, Alter B, Bonilla M, Boxer L . Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010; 150(2):196-9. PMC: 2906693. DOI: 10.1111/j.1365-2141.2010.08216.x. View

3.
Dong F, Brynes R, Tidow N, Welte K, Lowenberg B, Touw I . Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995; 333(8):487-93. DOI: 10.1056/NEJM199508243330804. View

4.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

5.
Kimmel M, Mathaes M . Modeling neutral evolution of Alu elements using a branching process. BMC Genomics. 2010; 11 Suppl 1:S11. PMC: 2822525. DOI: 10.1186/1471-2164-11-S1-S11. View